Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
CRSP
CRSP News & Events
-
Add to Watchlist
Trade CRSP
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
CRSP News
Cathie Wood's Investment Outlook for 2026
Jan 30 2026
Fool
CRISPR Therapeutics: A Promising Biotech Investment
Jan 29 2026
Fool
Wall Street Focuses on Earnings and Commodity Prices
Jan 29 2026
stocktwits
CRISPR Therapeutics Faces Renewed Pressure Amid Insider Sales
Jan 27 2026
Benzinga
Ark Invest Unveils 2026 Big Ideas, Forecasts 1.9% GDP Growth Boost
Jan 21 2026
Benzinga
Ark Invest Unveils 2026 Big Ideas, Focus on AI and Genomics
Jan 20 2026
Benzinga
CRISPR Therapeutics (CRSP) Options Trading Volume Hits 9,323 Contracts, 57.4% of Average Daily Volume
Jan 12 2026
NASDAQ.COM
CRISPR Therapeutics and Summit Therapeutics: Investment Outlook for 2026
Jan 12 2026
Fool
Show More News
CRSP Events
No data
CRSP Monitor News
CRISPR Therapeutics sets milestones for 2026 despite stock decline
Feb 05 2026
CRISPR Therapeutics Faces Pressure from Insider Sales and Weak Revenue
Jan 30 2026
CRISPR Therapeutics faces stock decline amid market trends
Jan 23 2026
Ark Invest highlights genomics potential, benefiting CRISPR Therapeutics
Jan 22 2026
CRISPR Therapeutics AG Rises Following Positive Clinical Updates
Jan 06 2026
CRISPR Therapeutics AG Surges on Acquisition Speculation
Dec 04 2025
CRSP Surges on Takeover Rumors, Crosses 5-Day SMA
Nov 17 2025
CRSP.O Surges Past 5-Day SMA Amid ARK's Strategic Moves
Nov 14 2025
CRSP Earnings Analysis
No Data
People Also Watch
